The present meta-analysis demonstrates that high FoxP3+ Tregs levels are associated with a favorable impact on CSS in patients with CRC, whereas fail to assign prognostic robustness to OS and DFS. The gene discussed is FOXP3; the disease is colorectal carcinoma.